Skip to content

Welcome to the 60th
EMWA Conference!

We are delighted to welcome you to the 60th EMWA Conference, taking place virtually this autumn. As we mark this milestone event, we invite you to join us online for a rich and flexible programme designed to support medical writers at every stage of their careers.
Booking is for EMWA members

Browse and fill a basket without an account. You must sign in as a member before you can check out.

«Back to the programme
WorkshopAdvancedDDA32 · 1 EPDP credits

DDA32 – Writing Development Safety Update Reports

Tuesday 10 November 2026 · 09:00-12:30 CET · Stefanie Rechtsteiner

Who it is for

This workshop is for medical writers who would like to obtain knowledge about the Development Safety Update Report (DSUR). Participants should have some experience of collection and analysis of safety data, and an understanding of safety monitoring during clinical trials. Participants without this knowledge or without experience in safety/pharmacovigilance writing should in advance attend the course DDF32.

What it covers

Since 2011, DSURs are required in the ICH region for all marketed drugs or drugs under development for which clinical trials are ongoing. The aim of this workshop is to explain what the DSUR is, when it needs to be written (and when possibly not), which data and information need to be included and how to present them. It also provides guidance on the writing and project management process, taking into account that the DSUR is a document that requires an interdisciplinary and well-organised team effort within challenging timelines. Concise as per guidance, with a clear and logical structure, the DSUR nevertheless has some pitfalls in store that are also discussed in this workshop. To bring life and colour to the theory, all of this is illustrated with examples from the daily practice of preparing and writing DSURs.

Workshop leaders
Stefanie Rechtsteiner

Stefanie has been working in the pharmaceutical industry for many years, starting in biotech, moving on to marketing/sales, until she specialised in safety writing from 2011 onwards. She has extensive hands-on experience on DSUR, RMP, AddCO, and PBRER writing and currently works as a principal pharmacovigilance writer at
Boehringer Ingelheim. Stefanie joined EMWA in 2011 and has offered various workshops on safety writing at EMWA over the past years.

Back To Top
Your Cart

Your cart is empty.